Analysts expect MedEquities Realty Trust Inc (NYSE:MRT) to report earnings per share (EPS) of $0.31 for the current fiscal quarter, Zacks Investment Research reports. Three analysts have provided estimates for MedEquities Realty Trust’s earnings, with the lowest EPS estimate coming in at $0.30 and the highest estimate coming in at $0.32. MedEquities Realty Trust posted earnings of $0.27 per share in the same quarter last year, which indicates a positive year-over-year growth rate of 14.8%. The company is expected to issue its next quarterly earnings results on Monday, February 26th.
According to Zacks, analysts expect that MedEquities Realty Trust will report full year earnings of $1.12 per share for the current year, with EPS estimates ranging from $1.11 to $1.13. For the next fiscal year, analysts anticipate that the company will report earnings of $1.26 per share, with EPS estimates ranging from $1.18 to $1.34. Zacks’ earnings per share averages are a mean average based on a survey of analysts that that provide coverage for MedEquities Realty Trust.
MedEquities Realty Trust (NYSE:MRT) last posted its quarterly earnings results on Tuesday, November 7th. The financial services provider reported $0.17 EPS for the quarter, missing the consensus estimate of $0.30 by ($0.13). MedEquities Realty Trust had a net margin of 35.61% and a return on equity of 5.88%. The business had revenue of $15.77 million during the quarter, compared to analyst estimates of $15.49 million.
MedEquities Realty Trust (MRT) traded down $0.17 during midday trading on Friday, reaching $10.84. The company had a trading volume of 360,700 shares, compared to its average volume of 198,222. MedEquities Realty Trust has a 12-month low of $10.06 and a 12-month high of $13.06. The stock has a market cap of $344.23, a P/E ratio of 27.10 and a beta of -0.74.
In related news, Director Randy L. Churchey purchased 5,300 shares of the company’s stock in a transaction on Monday, November 20th. The stock was bought at an average price of $10.87 per share, with a total value of $57,611.00. Following the completion of the transaction, the director now owns 46,776 shares of the company’s stock, valued at approximately $508,455.12. The acquisition was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website. Also, CEO John W. Mcroberts purchased 18,000 shares of the company’s stock in a transaction on Friday, November 17th. The shares were bought at an average cost of $10.74 per share, with a total value of $193,320.00. The disclosure for this purchase can be found here. Insiders purchased a total of 23,600 shares of company stock valued at $254,129 over the last ninety days. 2.50% of the stock is currently owned by company insiders.
A number of institutional investors have recently added to or reduced their stakes in MRT. Schwab Charles Investment Management Inc. increased its position in MedEquities Realty Trust by 59.0% during the second quarter. Schwab Charles Investment Management Inc. now owns 509,750 shares of the financial services provider’s stock worth $6,434,000 after buying an additional 189,219 shares in the last quarter. American Century Companies Inc. increased its position in MedEquities Realty Trust by 11.2% during the third quarter. American Century Companies Inc. now owns 1,726,208 shares of the financial services provider’s stock worth $20,283,000 after buying an additional 174,261 shares in the last quarter. State Street Corp increased its position in MedEquities Realty Trust by 41.7% during the second quarter. State Street Corp now owns 529,702 shares of the financial services provider’s stock worth $6,684,000 after buying an additional 155,934 shares in the last quarter. Prudential Financial Inc. increased its position in MedEquities Realty Trust by 5.4% during the third quarter. Prudential Financial Inc. now owns 2,658,837 shares of the financial services provider’s stock worth $31,242,000 after buying an additional 136,499 shares in the last quarter. Finally, OxFORD Asset Management LLP increased its position in MedEquities Realty Trust by 393.3% during the second quarter. OxFORD Asset Management LLP now owns 111,881 shares of the financial services provider’s stock worth $1,412,000 after buying an additional 89,200 shares in the last quarter. 93.19% of the stock is owned by institutional investors.
About MedEquities Realty Trust
MedEquities Realty Trust, Inc is a real estate investment trust (REIT). The Company invests in a diversified mix of healthcare properties and healthcare-related real estate debt investments. The Company invests primarily in real estate across the acute and post-acute spectrum of care. It focuses on investing in various types of healthcare properties, including acute care hospitals; skilled nursing facilities; short-stay surgical and specialty hospitals, which focus on orthopedic, heart and other dedicated surgeries and specialty procedures; dedicated specialty hospitals, such as inpatient rehabilitation facilities, long-term acute care hospitals and facilities providing psychiatric care; physician clinics; diagnostic facilities; outpatient surgery centers, and facilities that support these services, such as medical office buildings.
For more information about research offerings from Zacks Investment Research, visit Zacks.com
Receive News & Ratings for MedEquities Realty Trust Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for MedEquities Realty Trust and related companies with MarketBeat.com's FREE daily email newsletter.